Profile change history

What changed for Zilucoplan?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Zilucoplan identity.

25Total events
25Record additions
0Version changes
6Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 25 connected records →

Showing the latest 25 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 15, 2026.

Record added

ClinicalTrials.gov record NCT04297683

PeptideScanner retained ClinicalTrials.gov record NCT04297683 at 2026-11-15T21:46:36.651Z. Its registry update date was 2026-07-21, and PeptideScanner's reviewed identity mapping was zilucoplan.

PeptideScanner change date
November 15, 2026
Cited source date
July 21, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04382755

PeptideScanner retained ClinicalTrials.gov record NCT04382755 at 2026-11-15T21:46:36.651Z. Its registry update date was 2023-09-14, and PeptideScanner's reviewed identity mapping was zilucoplan.

PeptideScanner change date
November 15, 2026
Cited source date
September 14, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04436497

PeptideScanner retained ClinicalTrials.gov record NCT04436497 at 2026-11-15T21:46:36.651Z. Its registry update date was 2023-07-25, and PeptideScanner's reviewed identity mapping was zilucoplan.

PeptideScanner change date
November 15, 2026
Cited source date
July 25, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04590586

PeptideScanner retained ClinicalTrials.gov record NCT04590586 at 2026-11-15T21:46:36.651Z. Its registry update date was 2022-06-29, and PeptideScanner's reviewed identity mapping was zilucoplan.

PeptideScanner change date
November 15, 2026
Cited source date
June 29, 2022
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06055959

PeptideScanner retained ClinicalTrials.gov record NCT06055959 at 2026-11-15T21:46:36.651Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was zilucoplan.

PeptideScanner change date
November 15, 2026
Cited source date
November 5, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06435312

PeptideScanner retained ClinicalTrials.gov record NCT06435312 at 2026-11-15T21:46:36.651Z. Its registry update date was 2026-10-02, and PeptideScanner's reviewed identity mapping was zilucoplan.

PeptideScanner change date
November 15, 2026
Cited source date
October 2, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06471361

PeptideScanner retained ClinicalTrials.gov record NCT06471361 at 2026-11-15T21:46:36.651Z. Its registry update date was 2026-03-27, and PeptideScanner's reviewed identity mapping was zilucoplan.

PeptideScanner change date
November 15, 2026
Cited source date
March 27, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06511076

PeptideScanner retained ClinicalTrials.gov record NCT06511076 at 2026-11-15T21:46:36.651Z. Its registry update date was 2026-01-06, and PeptideScanner's reviewed identity mapping was zilucoplan.

PeptideScanner change date
November 15, 2026
Cited source date
January 6, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06815133

PeptideScanner retained ClinicalTrials.gov record NCT06815133 at 2026-11-15T21:46:36.651Z. Its registry update date was 2025-12-03, and PeptideScanner's reviewed identity mapping was zilucoplan.

PeptideScanner change date
November 15, 2026
Cited source date
December 3, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06961747

PeptideScanner retained ClinicalTrials.gov record NCT06961747 at 2026-11-15T21:46:36.651Z. Its registry update date was 2026-08-27, and PeptideScanner's reviewed identity mapping was zilucoplan.

PeptideScanner change date
November 15, 2026
Cited source date
August 27, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07215949

PeptideScanner retained ClinicalTrials.gov record NCT07215949 at 2026-11-15T21:46:36.651Z. Its registry update date was 2026-08-28, and PeptideScanner's reviewed identity mapping was zilucoplan.

PeptideScanner change date
November 15, 2026
Cited source date
August 28, 2026
Evidence lane
Clinical trials
Record added

Federal Register notice 2025-09068

The Federal Register published notice 2025-09068, attributed to FDA and its parent HHS department, on 2025-05-21. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Zilucoplan.

PeptideScanner change date
November 15, 2026
Cited source date
May 21, 2025
Evidence lane
Regulatory
Record added

Federal Register notice 2025-11314

The Federal Register published notice 2025-11314, attributed to FDA and its parent HHS department, on 2025-06-20. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; ZILBRYSQ,” and PeptideScanner's exact reviewed identity mapping connects the document to Zilucoplan.

PeptideScanner change date
November 15, 2026
Cited source date
June 20, 2025
Evidence lane
Regulatory
Record added

Chemical synthesis and characterisation of the complement C5 inhibitory peptide zilucoplan.

PubMed lists PMID 33398524 in Amino acids as Journal Article, with publication-date metadata of 2021-01-04 (day precision). PeptideScanner associated the retained record with the identity slug zilucoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 20, 2021
Evidence lane
Literature metadata
Record added

Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria.

PubMed lists PMID 37534517 in Haematologica as Clinical Trial, Phase II, Letter, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-03-01 (day precision). PeptideScanner associated the retained record with the identity slug zilucoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 16, 2024
Evidence lane
Literature metadata
Record added

Zilucoplan (Zilbrysq) for myasthenia gravis.

PubMed lists PMID 38576149 in The Medical letter on drugs and therapeutics as Journal Article, with publication-date metadata of 2024-04-15 (day precision). PeptideScanner associated the retained record with the identity slug zilucoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
April 8, 2024
Evidence lane
Literature metadata
Record added

Usability of the zilucoplan prefilled syringe for the treatment of generalized myasthenia gravis: insights from a human factors validation study.

PubMed lists PMID 39403865 in Expert review of medical devices as Journal Article, Validation Study, with publication-date metadata of 2024-10-15 (day precision). PeptideScanner associated the retained record with the identity slug zilucoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 15, 2024
Evidence lane
Literature metadata
Record added

Zilucoplan as a fast-acting treatment for severe myasthenic exacerbation: A case series.

PubMed lists PMID 40685269 in Revue neurologique as Letter, with publication-date metadata of 2025-07-19 (day precision). PeptideScanner associated the retained record with the identity slug zilucoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 11, 2025
Evidence lane
Literature metadata
Record added

Manifestation of morphea in a patient with myasthenia gravis under therapy with zilucoplan.

PubMed lists PMID 41058183 in Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG as Case Reports, Journal Article, with publication-date metadata of 2025-10-07 (day precision). PeptideScanner associated the retained record with the identity slug zilucoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
February 7, 2026
Evidence lane
Literature metadata
Record added

Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study.

PubMed lists PMID 41314023 in Journal of the neurological sciences as Journal Article, Multicenter Study, Observational Study, with publication-date metadata of 2025-11-24 (day precision). PeptideScanner associated the retained record with the identity slug zilucoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 1, 2026
Evidence lane
Literature metadata
Record added

Letter to the editor: Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study.

PubMed lists PMID 41604997 in Journal of the neurological sciences as Letter, with publication-date metadata of 2026-01-23 (day precision). PeptideScanner associated the retained record with the identity slug zilucoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
February 23, 2026
Evidence lane
Literature metadata
Record added

Letter to editor: Early real-life experience on zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study.

PubMed lists PMID 41653661 in Journal of the neurological sciences as Letter, with publication-date metadata of 2026-01-22 (day precision). PeptideScanner associated the retained record with the identity slug zilucoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
February 23, 2026
Evidence lane
Literature metadata
Record added

Zilucoplan as a rescue therapy in myasthenic crisis: a case description and summary of early report experiences.

PubMed lists PMID 42467314 in Acta neurologica Belgica as Letter, with publication-date metadata of 2026-07-17 (day precision). PeptideScanner associated the retained record with the identity slug zilucoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 28, 2026
Evidence lane
Literature metadata
Record added

A rare case of morphea following zilucoplan treatment for generalized myasthenia gravis.

PubMed lists PMID 42604018 in JAAD case reports as Case Reports, Journal Article, with publication-date metadata of 2026-07-10 (day precision). PeptideScanner associated the retained record with the identity slug zilucoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 17, 2026
Evidence lane
Literature metadata